Get started
Cresco Labs Inc.Cresco Labs Inc.Cresco Labs Inc.

Cresco Labs Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

CRLBF chart


Full chart

CRLBF upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪683.52 M‬USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.50USD
Net income (FY)
‪−178.74 M‬USD
Revenue (FY)
‪785.02 M‬USD
Shares float
‪325.67 M‬
Beta (1Y)
1.29

Employees


Employees (FY)
‪2.76 K‬
Change (1Y)
−440 −13.75%
Revenue / Employee (1Y)
‪284.43 K‬USD
Net income / Employee (1Y)
‪−64.76 K‬USD

About CRESCO LABS INC.


Sector
Process Industries
Industry
Agricultural Commodities/Milling
CEO
Charles Bachtell
Website
crescolabs.com
Headquarters
Chicago
Founded
1990
FIGI
BBG00MQB5Q05
Cresco Labs Inc. engages in cultivating medical grade cannabis, manufacturing medical products derived from cannabis cultivation, and distributing such products to medical or adult use consumers. It focuses on regulatory compliance while working to develop condition-specific strains of cannabis and non-invasive delivery methods. The company was founded by Charles Bachtel, Joseph Caltabiano, Dominic Sergi, Rob Sampson, and Brian McCormack on July 6, 1990 and is headquartered in Chicago, IL.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas



See all ideas 

CRLBF news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Sparks


Curated watchlists where CRLBF is featured.

See all sparks 

Frequently Asked Questions


The current price of CRLBF is 1.52 USD — it has increased by 3.77% in the past 24 hours. Watch Cresco Labs Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Cresco Labs Inc. stocks are traded under the ticker CRLBF.
CRLBF stock has fallen by −7.06% compared to the previous week, the month change is a −7.62% fall, over the last year Cresco Labs Inc. has showed a 21.20% increase.
We've gathered analysts' opinions on Cresco Labs Inc. future price: according to them, CRLBF price has a max estimate of 4.32 USD and a min estimate of 2.50 USD. Watch CRLBF chart and read a more detailed Cresco Labs Inc. stock forecast: see what analysts think of Cresco Labs Inc. and suggest that you do with its stocks.
CRLBF reached its all-time high on Feb 10, 2021 with the price of 17.49 USD, and its all-time low was 1.00 USD and was reached on Aug 15, 2023. View more price dynamics on CRLBF chart.
See other stocks reaching their highest and lowest prices.
CRLBF stock is 6.25% volatile and has beta coefficient of 1.29. Track Cresco Labs Inc. stock price on the chart and check out the list of the most volatile stocks — is Cresco Labs Inc. there?
Today Cresco Labs Inc. has the market capitalization of ‪515.76 M‬, it has decreased by −9.20% over the last week.
Yes, you can track Cresco Labs Inc. financials in yearly and quarterly reports right on TradingView.
Cresco Labs Inc. is going to release the next earnings report on Nov 8, 2024. Keep track of upcoming events with our Earnings Calendar.
CRLBF earnings for the last quarter are −0.15 USD per share, whereas the estimation was 0.01 USD resulting in a ‪−1.27 K‬% surprise. The estimated earnings for the next quarter are 0.01 USD per share. See more details about Cresco Labs Inc. earnings.
Cresco Labs Inc. revenue for the last quarter amounts to ‪184.00 M‬ USD, despite the estimated figure of ‪184.66 M‬ USD. In the next quarter, revenue is expected to reach ‪185.93 M‬ USD.
CRLBF net income for the last quarter is ‪−54.32 M‬ USD, while the quarter before that showed ‪−5.17 M‬ USD of net income which accounts for −950.73% change. Track more Cresco Labs Inc. financial stats to get the full picture.
No, CRLBF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 2, 2024, the company has ‪2.76 K‬ employees. See our rating of the largest employees — is Cresco Labs Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Cresco Labs Inc. EBITDA is ‪181.41 M‬ USD, and current EBITDA margin is 17.19%. See more stats in Cresco Labs Inc. financial statements.
Like other stocks, CRLBF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Cresco Labs Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Cresco Labs Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Cresco Labs Inc. stock shows the sell signal. See more of Cresco Labs Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.